Cargando…
Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
Clinical relapses are common in anti-neutrophil cytoplasm antibody (ANCA)–associated vasculitis, necessitating repeated treatment with immunosuppressive therapy, and increasing the risks of severe adverse events. Better understanding the basis of relapse would help stratify patients, testing the not...
Autor principal: | Salama, Alan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943777/ https://www.ncbi.nlm.nih.gov/pubmed/31922056 http://dx.doi.org/10.1016/j.ekir.2019.10.005 |
Ejemplares similares
-
Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody(ANCA)-associated vasculitis
por: Tsukui, Daisuke, et al.
Publicado: (2021) -
Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management
por: Plumb, Lucy A, et al.
Publicado: (2017) -
Hydralazine-Induced Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
por: Echevarria, Victoria, et al.
Publicado: (2023) -
Predicting relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis: a Systematic review and meta-analysis
por: King, Catherine, et al.
Publicado: (2021) -
From Kidney to Brain: An Uncommon Severe Relapse of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody (MPO-ANCA) Vasculitis
por: Araújo, Tiago, et al.
Publicado: (2021)